Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Differences in enzyme activity and androgen receptors in hair follicles may explain why hair loss appears differently in men and women.

Protein composition greatly affects the function of keratin biomaterials.

Finasteride may affect brain chemistry and behavior, offering potential for treating certain mental health conditions.

Chemical treatments change hair surface properties, making it more hydrophilic and able to bind conditioners.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Computational techniques can improve drug development for treating certain conditions.

The new hydrogel helps heal diabetic wounds by reducing inflammation and improving tissue repair.

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

New hybrid compound found to effectively prevent hair loss.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

A new compound effectively inhibits human 5α-reductase 1.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Compounds from the plant Mammea siamensis may help treat hair loss.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

New compounds were made that effectively block a specific enzyme related to androgen conditions.